{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:50:31Z","timestamp":1740135031633,"version":"3.37.3"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T00:00:00Z","timestamp":1559779200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T00:00:00Z","timestamp":1559779200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["26461602","17K10132","24249061","22791507"],"award-info":[{"award-number":["26461602","17K10132","24249061","22791507"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Cancer Centre","award":["Research and Development Fund (4)"],"award-info":[{"award-number":["Research and Development Fund (4)"]}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["P-Direct"],"award-info":[{"award-number":["P-Direct"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12885-019-5772-4","type":"journal-article","created":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T14:03:09Z","timestamp":1559829789000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Programmed expression of pro-apoptotic BMCC1 during apoptosis, triggered by DNA damage in neuroblastoma cells"],"prefix":"10.1186","volume":"19","author":[{"given":"Mohammad Sazzadul","family":"Islam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Takano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoki","family":"Yokochi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesmin","family":"Akter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohko","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Nakagawara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2646-7410","authenticated-orcid":false,"given":"Yasutoshi","family":"Tatsumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,6]]},"reference":[{"issue":"3","key":"5772_CR1","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrc1014","volume":"3","author":"GM Brodeur","year":"2003","unstructured":"Brodeur GM. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer. 2003;3(3):203\u201316.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"5772_CR2","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00441-017-2761-2","volume":"372","author":"Garrett M. Brodeur","year":"2018","unstructured":"Brodeur GM. Spontaneous regression of neuroblastoma. Cell and tissue research. 2018;372(2):277\u201386.","journal-title":"Cell and Tissue Research"},{"issue":"13","key":"5772_CR3","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1038\/sj.onc.1209225","volume":"25","author":"T Machida","year":"2006","unstructured":"Machida T, Fujita T, Ooo ML, Ohira M, Isogai E, Mihara M, Hirato J, Tomotsune D, Hirata T, Fujimori M, et al. Increased expression of proapoptotic BMCC1, a novel gene with the BNIP2 and Cdc42GAP homology (BCH) domain, is associated with favorable prognosis in human neuroblastomas. Oncogene. 2006;25(13):1931\u201342.","journal-title":"Oncogene"},{"issue":"17","key":"5772_CR4","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.1016\/j.febslet.2012.04.023","volume":"586","author":"CQ Pan","year":"2012","unstructured":"Pan CQ, Low BC. Functional plasticity of the BNIP-2 and Cdc42GAP homology (BCH) domain in cell signaling and cell dynamics. FEBS Lett. 2012;586(17):2674\u201391.","journal-title":"FEBS Lett"},{"key":"5772_CR5","doi-asserted-by":"publisher","first-page":"e1607","DOI":"10.1038\/cddis.2014.568","volume":"6","author":"Y Tatsumi","year":"2015","unstructured":"Tatsumi Y, Takano R, Islam MS, Yokochi T, Itami M, Nakamura Y, Nakagawara A. BMCC1, which is an interacting partner of BCL2, attenuates AKT activity, accompanied by apoptosis. Cell Death Dis. 2015;6:e1607.","journal-title":"Cell Death Dis"},{"issue":"1","key":"5772_CR6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.bbrc.2016.07.089","volume":"478","author":"MS Islam","year":"2016","unstructured":"Islam MS, Tatsumi Y, Takano R, Yokochi T, Akter J, Ozaki T, Nakamura Y, Ohira M, Nakagawara A. Transcriptional regulation of BMCC1 mediated by E2F1 in neuroblastoma cells. Biochem Biophys Res Commun. 2016;478(1):81\u20136.","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"5772_CR7","first-page":"739","volume":"6","author":"J DeGregori","year":"2006","unstructured":"DeGregori J, Johnson DG. Distinct and overlapping roles for E2F family members in transcription, proliferation and apoptosis. Curr Mol Med. 2006;6(7):739\u201348.","journal-title":"Curr Mol Med"},{"issue":"17","key":"5772_CR8","first-page":"3640","volume":"57","author":"Y Huang","year":"1997","unstructured":"Huang Y, Ishiko T, Nakada S, Utsugisawa T, Kato T, Yuan ZM. Role for E2F in DNA damage-induced entry of cells into S phase. Cancer Res. 1997;57(17):3640\u20133.","journal-title":"Cancer Res"},{"issue":"5","key":"5772_CR9","doi-asserted-by":"publisher","first-page":"3704","DOI":"10.1128\/MCB.19.5.3704","volume":"19","author":"C Blattner","year":"1999","unstructured":"Blattner C, Sparks A, Lane D. Transcription factor E2F-1 is upregulated in response to DNA damage in a manner analogous to that of p53. Mol Cell Biol. 1999;19(5):3704\u201313.","journal-title":"Mol Cell Biol"},{"issue":"2","key":"5772_CR10","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1093\/nar\/27.2.491","volume":"27","author":"M Hofferer","year":"1999","unstructured":"Hofferer M, Wirbelauer C, Humar B, Krek W. Increased levels of E2F-1-dependent DNA binding activity after UV- or gamma-irradiation. Nucleic Acids Res. 1999;27(2):491\u20135.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"5772_CR11","first-page":"5","volume":"14","author":"RD Meng","year":"1999","unstructured":"Meng RD, Phillips P, El-Deiry WS. p53-independent increase in E2F-1 expression enhances the cytotoxic effects of etoposide and of adriamycin. Int J Oncol. 1999;14(1):5\u201314.","journal-title":"Int J Oncol"},{"issue":"14","key":"5772_CR12","first-page":"1833","volume":"15","author":"WC Lin","year":"2001","unstructured":"Lin WC, Lin FT, Nevins JR. Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation. Genes Dev. 2001;15(14):1833\u201344.","journal-title":"Genes Dev"},{"issue":"5","key":"5772_CR13","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/ncb974","volume":"5","author":"C Stevens","year":"2003","unstructured":"Stevens C, Smith L, La Thangue NB. Chk2 activates E2F-1 in response to DNA damage. Nat Cell Biol. 2003;5(5):401\u20139.","journal-title":"Nat Cell Biol"},{"issue":"29","key":"5772_CR14","doi-asserted-by":"publisher","first-page":"30830","DOI":"10.1074\/jbc.M402403200","volume":"279","author":"A Ianari","year":"2004","unstructured":"Ianari A, Gallo R, Palma M, Alesse E, Gulino A. Specific role for p300\/CREB-binding protein-associated factor activity in E2F1 stabilization in response to DNA damage. J Biol Chem. 2004;279(29):30830\u20135.","journal-title":"J Biol Chem"},{"issue":"6804","key":"5772_CR15","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/35036614","volume":"407","author":"M Irwin","year":"2000","unstructured":"Irwin M, Marin MC, Phillips AC, Seelan RS, Smith DI, Liu W, Flores ER, Tsai KY, Jacks T, Vousden KH, et al. Role for the p53 homologue p73 in E2F-1-induced apoptosis. Nature. 2000;407(6804):645\u20138.","journal-title":"Nature"},{"issue":"4","key":"5772_CR16","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/82617","volume":"26","author":"T Stiewe","year":"2000","unstructured":"Stiewe T, Putzer BM. Role of the p53-homologue p73 in E2F1-induced apoptosis. Nat Genet. 2000;26(4):464\u20139.","journal-title":"Nat Genet"},{"issue":"6","key":"5772_CR17","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/ncb998","volume":"5","author":"N Pediconi","year":"2003","unstructured":"Pediconi N, Ianari A, Costanzo A, Belloni L, Gallo R, Cimino L, Porcellini A, Screpanti I, Balsano C, Alesse E, et al. Differential regulation of E2F1 apoptotic target genes in response to DNA damage. Nat Cell Biol. 2003;5(6):552\u20138.","journal-title":"Nat Cell Biol"},{"issue":"6","key":"5772_CR18","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/35078527","volume":"3","author":"MC Moroni","year":"2001","unstructured":"Moroni MC, Hickman ES, Lazzerini Denchi E, Caprara G, Colli E, Cecconi F, Muller H, Helin K. Apaf-1 is a transcriptional target for E2F and p53. Nat Cell Biol. 2001;3(6):552\u20138.","journal-title":"Nat Cell Biol"},{"issue":"12","key":"5772_CR19","first-page":"3743","volume":"9","author":"Q Zhan","year":"1994","unstructured":"Zhan Q, Fan S, Bae I, Guillouf C, Liebermann DA, O'Connor PM, Fornace AJ Jr. Induction of bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis. Oncogene. 1994;9(12):3743\u201351.","journal-title":"Oncogene"},{"issue":"3","key":"5772_CR20","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/S1097-2765(01)00214-3","volume":"7","author":"K Nakano","year":"2001","unstructured":"Nakano K, Vousden KH. PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell. 2001;7(3):683\u201394.","journal-title":"Mol Cell"},{"issue":"27","key":"5772_CR21","doi-asserted-by":"publisher","first-page":"28367","DOI":"10.1074\/jbc.M313526200","volume":"279","author":"AG Yakovlev","year":"2004","unstructured":"Yakovlev AG, Di Giovanni S, Wang G, Liu W, Stoica B, Faden AI. BOK and NOXA are essential mediators of p53-dependent apoptosis. J Biol Chem. 2004;279(27):28367\u201374.","journal-title":"J Biol Chem"},{"issue":"17","key":"5772_CR22","doi-asserted-by":"publisher","first-page":"11549","DOI":"10.1074\/jbc.274.17.11549","volume":"274","author":"H Zou","year":"1999","unstructured":"Zou H, Li Y, Liu X, Wang X. An APAF-1.Cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J Biol Chem. 1999;274(17):11549\u201356.","journal-title":"J Biol Chem"},{"issue":"7","key":"5772_CR23","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/cdd.2009.29","volume":"16","author":"S Inoue","year":"2009","unstructured":"Inoue S, Browne G, Melino G, Cohen GM. Ordering of caspases in cells undergoing apoptosis by the intrinsic pathway. Cell Death Differ. 2009;16(7):1053\u201361.","journal-title":"Cell Death Differ"},{"issue":"3","key":"5772_CR24","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.bbrc.2007.10.018","volume":"364","author":"CA Valencia","year":"2007","unstructured":"Valencia CA, Cotten SW, Liu R. Cleavage of BNIP-2 and BNIP-XL by caspases. Biochem Biophys Res Commun. 2007;364(3):495\u2013501.","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"5772_CR25","doi-asserted-by":"publisher","first-page":"7076","DOI":"10.1074\/jbc.M108255200","volume":"277","author":"T Ueda","year":"2002","unstructured":"Ueda T, Bruchovsky N, Sadar MD. Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways. J Biol Chem. 2002;277(9):7076\u201385.","journal-title":"J Biol Chem"},{"issue":"5","key":"5772_CR26","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1073\/pnas.0308050100","volume":"101","author":"D Chen","year":"2004","unstructured":"Chen D, Zhou Q. Caspase cleavage of BimEL triggers a positive feedback amplification of apoptotic signaling. Proc Natl Acad Sci U S A. 2004;101(5):1235\u201340.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"29","key":"5772_CR27","doi-asserted-by":"publisher","first-page":"17907","DOI":"10.1074\/jbc.272.29.17907","volume":"272","author":"NA Thornberry","year":"1997","unstructured":"Thornberry NA, Rano TA, Peterson EP, Rasper DM, Timkey T, Garcia-Calvo M, Houtzager VM, Nordstrom PA, Roy S, Vaillancourt JP, et al. A combinatorial approach defines specificities of members of the caspase family and granzyme B. functional relationships established for key mediators of apoptosis. J Biol Chem. 1997;272(29):17907\u201311.","journal-title":"J Biol Chem"},{"issue":"20","key":"5772_CR28","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.1038\/sj.onc.1208493","volume":"24","author":"C Lemaire","year":"2005","unstructured":"Lemaire C, Godefroy N, Costina-Parvu I, Rincheval V, Renaud F, Trotot P, Bouleau S, Mignotte B, Vayssiere JL. Caspase-9 can antagonize p53-induced apoptosis by generating a p76(Rb) truncated form of Rb. Oncogene. 2005;24(20):3297\u2013308.","journal-title":"Oncogene"},{"issue":"36","key":"5772_CR29","doi-asserted-by":"publisher","first-page":"22966","DOI":"10.1074\/jbc.272.36.22966","volume":"272","author":"L Chen","year":"1997","unstructured":"Chen L, Marechal V, Moreau J, Levine AJ, Chen J. Proteolytic cleavage of the mdm2 oncoprotein during apoptosis. J Biol Chem. 1997;272(36):22966\u201373.","journal-title":"J Biol Chem"},{"issue":"4","key":"5772_CR30","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1158\/1541-7786.203.2.4","volume":"2","author":"JT Powers","year":"2004","unstructured":"Powers JT, Hong S, Mayhew CN, Rogers PM, Knudsen ES, Johnson DG. E2F1 uses the ATM signaling pathway to induce p53 and Chk2 phosphorylation and apoptosis. Mol Cancer Res. 2004;2(4):203\u201314.","journal-title":"Mol Cancer Res"},{"issue":"7","key":"5772_CR31","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1128\/MCB.24.7.2968-2977.2004","volume":"24","author":"HA Rogoff","year":"2004","unstructured":"Rogoff HA, Pickering MT, Frame FM, Debatis ME, Sanchez Y, Jones S, Kowalik TF. Apoptosis associated with deregulated E2F activity is dependent on E2F1 and Atm\/Nbs1\/Chk2. Mol Cell Biol. 2004;24(7):2968\u201377.","journal-title":"Mol Cell Biol"},{"issue":"23","key":"5772_CR32","doi-asserted-by":"publisher","first-page":"3258","DOI":"10.1038\/sj.onc.1209352","volume":"25","author":"FM Frame","year":"2006","unstructured":"Frame FM, Rogoff HA, Pickering MT, Cress WD, Kowalik TF. E2F1 induces MRN foci formation and a cell cycle checkpoint response in human fibroblasts. Oncogene. 2006;25(23):3258\u201366.","journal-title":"Oncogene"},{"issue":"8","key":"5772_CR33","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.4161\/cc.10.8.15341","volume":"10","author":"J Chen","year":"2011","unstructured":"Chen J, Zhu F, Weaks RL, Biswas AK, Guo R, Li Y, Johnson DG. E2F1 promotes the recruitment of DNA repair factors to sites of DNA double-strand breaks. Cell Cycle. 2011;10(8):1287\u201394.","journal-title":"Cell Cycle"},{"issue":"4","key":"5772_CR34","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S0092-8674(00)81590-1","volume":"94","author":"H Li","year":"1998","unstructured":"Li H, Zhu H, Xu CJ, Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell. 1998;94(4):491\u2013501.","journal-title":"Cell"},{"issue":"9","key":"5772_CR35","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1128\/MCB.21.9.3025-3036.2001","volume":"21","author":"F Condorelli","year":"2001","unstructured":"Condorelli F, Salomoni P, Cotteret S, Cesi V, Srinivasula SM, Alnemri ES, Calabretta B. Caspase cleavage enhances the apoptosis-inducing effects of BAD. Mol Cell Biol. 2001;21(9):3025\u201336.","journal-title":"Mol Cell Biol"},{"issue":"27","key":"5772_CR36","doi-asserted-by":"publisher","first-page":"8403","DOI":"10.1073\/pnas.1507882112","volume":"112","author":"A Salameh","year":"2015","unstructured":"Salameh A, Lee AK, Cardo-Vila M, Nunes DN, Efstathiou E, Staquicini FI, Dobroff AS, Marchio S, Navone NM, Hosoya H, et al. PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA PCA3. Proc Natl Acad Sci U S A. 2015;112(27):8403\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"18","key":"5772_CR37","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1158\/0008-5472.CAN-15-0702","volume":"75","author":"PW Harms","year":"2015","unstructured":"Harms PW, Vats P, Verhaegen ME, Robinson DR, Wu YM, Dhanasekaran SM, Palanisamy N, Siddiqui J, Cao X, Su F, et al. The distinctive mutational spectra of polyomavirus-negative Merkel cell carcinoma. Cancer Res. 2015;75(18):3720\u20137.","journal-title":"Cancer Res"},{"issue":"2","key":"5772_CR38","doi-asserted-by":"publisher","first-page":"E360","DOI":"10.1210\/jc.2014-3238","volume":"100","author":"W Yu","year":"2015","unstructured":"Yu W, McPherson JR, Stevenson M, van Eijk R, Heng HL, Newey P, Gan A, Ruano D, Huang D, Poon SL, et al. Whole-exome sequencing studies of parathyroid carcinomas reveal novel PRUNE2 mutations, distinctive mutational spectra related to APOBEC-catalyzed DNA mutagenesis and mutational enrichment in kinases associated with cell migration and invasion. J Clin Endocrinol Metab. 2015;100(2):E360\u20134.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5772-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-5772-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5772-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T18:18:08Z","timestamp":1663611488000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-5772-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,6]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["5772"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-5772-4","relation":{},"ISSN":["1471-2407"],"issn-type":[{"type":"electronic","value":"1471-2407"}],"subject":[],"published":{"date-parts":[[2019,6,6]]},"assertion":[{"value":"26 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval is not required in this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that there are no competing financial interests in relation to the work described.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"542"}}